Loading...
Mesothelin as a target for chimeric antigen receptor-modified T cells as anticancer therapy
Mesothelin is a promising target for immune-based therapy, specifically for mesothelioma and pancreatic and ovarian cancers that have high levels of mesothelin expression. Many preclinical and clinical studies that target tumors with high mesothelin expression with antibodies, immunotoxins, antibody...
Na minha lista:
| Udgivet i: | Immunotherapy |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Future Medicine Ltd
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5619020/ https://ncbi.nlm.nih.gov/pubmed/26973126 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt.16.4 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|